Song Xu

Song Xu | Editor

Affilation: Tianjin Medical University General Hospital, P.R.China

Song Xu was born on January 18, 1982 in Tianjin, P.R. China. Since 2000, he was enrolled in the Faculty of Clinical Medicine in Tianjin Medical University. Besides his study and training in clinical medicine he was also devoted to scientific research. From 2006 to 2007, he worked on gene therapy in glioma for his mater thesis in the Neuro-oncology Laboratory, Neurological Institution of Tianjin Medical University General Hospital under the supervision of Prof. Dr. Pu Peiyu. This work was published in several (inter) national peer-reviewed journals. In June 2007, he obtained his master degree (M.D.) with great distinction, and was subsequently appointed as a surgeon in the department of lung cancer surgery, Tianjin Medical University General Hospital. In October 2007, Song Xu got a scholarship from the China Scholarship Council (CSC) and started his PhD study at the Vrije Universiteit Brussel (Belgium) in the research group Hematology and Immunology under the supervision of Prof. Dr. Ivan Van Riet and Prof. Dr. Karin Vanderkerken until September 2012. His research work was focused on the role of mesenchymal stem cells in the tumor microenvironment of multiple myeloma. His findings have been presented during several (inter)national meetings and were published in high-ranked international peer-reviewed journals, such as Leukemia and Stem cells. In addition, during the PhD study, Song Xu has guided 3 master students as a supervisor. Now he is appointed as a thoracic surgeon in Tianjin Medical University General Hospital. Besides clinical work, he was also involved in the scientific research for lung cancer in the Tianjin Lung Cancer Institute. His main interest was the tumor microenvironment in the lung cancer growth, metastasis and drug resistance, which was supported by several national and local research grants. Recently, he was also devoted in the study of tumor driver gene mutation by NGS method in lung cancer and other malignancies. And he was interested in the CTCs and ctDNA study in lung ca.